NEW YORK (GenomeWeb) – NanoString Technologies yesterday reported preliminary fourth quarter and full-year 2015 financial results, with total revenues increasing about 40 percent and 30 percent, respectively.

Seattle-based NanoString projected total Q4 revenue of $21.1 million to $22.1 million, an increase of 35 percent to 42 percent over the prior year period. It also expects full-year revenues of $61.5 million to $62.5 million, an increase of 29 percent to 31 percent over fiscal year 2014, and within the firm's guidance of $60 million to $63 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that researchers in Italy are testing a gene drive aimed at controlling mosquito populations.

Researchers may experience the effects of the government shutdown for a while, the Los Angeles Times reports.

A new study finds that the majority of patients at a Tijuana clinic received a diagnosis after first-line genome sequencing, the San Diego Union-Tribune reports.

In Genome Biology this week: post-transcriptional modification-based stratification of glioblastoma, single-cell analysis of gene expression and methylation in human iPSCs, and more.